Individual hematopoietic stem cells in human bone marrow of patients with aplastic anemia or myelodysplastic syndrome stably give rise to limited cell lineages

Stem Cells

Volumn 31, Issue 3, 2013, Pages 536-546

  Katagiri, Takamasa ^a   Kawamoto, Hiroshi ^b   Nakakuki, Takashi ^c   Ishiyama, Ken ^a   Okada Hatakeyama, Mariko ^b   Ohtake, Shigeki ^a   Seiki, Yu ^a   Hosokawa, Kohei ^a   Nakao, Shinji ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b Institute of Physical and Chemical Research   (Japan)

^c KOGAKUIN UNIVERSITY   (Japan)

Author keywords

Aplastic anemia; Bone marrow; Differentiation; Experimental models; Fluorescence activated cell sorting; Hematopoietic progenitors; Hemopoietic stem cells

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN;

APLASTIC ANEMIA; ARTICLE; BONE MARROW; CELL LINEAGE; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MAJOR CLINICAL STUDY; MICROENVIRONMENT; MYELODYSPLASTIC SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; BONE MARROW CELLS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL LINEAGE; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOSYLPHOSPHATIDYLINOSITOLS; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; YOUNG ADULT;

EID: 84874881274     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1301     Document Type: Article

References (34)

1. Buescher ES, Alling DW, Gallin JI. Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. J Clin Invest 1985;76: 1581-1584.
2. Traulsen A, Pacheco JM, Luzzatto L et al. Somatic mutations and the hierarchy of hematopoiesis. Bioessays 2010;32: 1003-1008.
3. Wang H, Chuhjo T, Yasue S et al. Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood 2002;100: 3897-3902.
4. Nishimura J, Inoue N, Wada H et al. A patient with paroxysmal nocturnal hemoglobinuria bearing four independent PIG-A mutant clones. Blood 1997;89: 3470-3476.
5. Rosti V, Tremml G, Soares V et al. Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest 1997;100: 1028-1036.
6. Maciejewski JP, Sloand EM, Sato T et al. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol- anchored protein-deficient clone. Blood 1997;89: 1173-1181.
7. Araten DJ, Luzzatto L. The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood 2006;108: 734-736.
8. Traulsen A, Pacheco JM, Dingli D. On the origin of multiple mutant clones in paroxysmal nocturnal hemoglobinuria. Stem Cells 2007;25: 3081-3084.
9. Dingli D, Luzzatto L, Pacheco JM. Neutral evolution in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA 2008;105: 18496-18500.
10. Hillmen P, Lewis SM, Bessler M et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;333: 1253-1258.
11. Sugimori C, Mochizuki K, Qi Z et al. Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure. Br J Haematol 2009;147: 102-112.
12. Sugimori C, Chuhjo T, Feng X et al. Minor population of CD55- CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood 2006;107: 1308-1314.
13. Camitta BM, Thomas ED, Nathan DG et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979;53: 504-514.
14. Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the acute leukaemias. French-American-British (Fab) co-operative Group. Br J Haematol 1976;33: 451-458.
15. Araten DJ, Nafa K, Pakdeesuwan K et al. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci USA 1999;96: 5209-5214.
16. Katagiri T, Qi Z, Ohtake S et al. GPI-anchored protein-deficient T cells in patients with aplastic anemia and low-risk myelodysplastic syndrome: Implications for the immunopathophysiology of bone marrow failure. Eur J Haematol 2011;86: 226-236.
17. Mochizuki K, Sugimori C, Qi Z et al. Expansion of donor-derived hematopoietic stem cells with PIGA mutation associated with late graft failure after allogeneic stem cell transplantation. Blood 2008; 112: 2160-2162.
18. Mayawala K, Vlachos DG, Edwards JS. Computational modeling reveals molecular details of epidermal growth factor binding. BMC Cell Biol 2005;6: 41.
19. Jayawardhana B, Kell DB, Rattray M. Bayesian inference of the sites of perturbations in metabolic pathways via Markov chain Monte Carlo. Bioinformatics 2008;24: 1191-1197.
20. Pu JJ, Hu R, Mukhina GL et al. The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells. Haematologica 2012;97: 1225-1233.
21. Kawamoto H, Katsura Y. A new paradigm for hematopoietic cell lineages: Revision of the classical concept of the myeloid-lymphoid dichotomy. Trends Immunol 2009;30: 193-200.
22. Doulatov S, Notta F, Eppert K et al. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol 2010;11: 585-593.
23. Muller-Sieburg CE, Cho RH, Karlsson L et al. Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness. Blood 2004;103: 4111-4118.
24. Dykstra B, Kent D, Bowie M et al. Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 2007; 1: 218-229.
25. Beerman I, Bhattacharya D, Zandi S et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci USA 2010;107: 5465-5470.
26. Morita Y, Ema H, Nakauchi H. Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J Exp Med 2010;207: 1173-1182.
27. Cavazzana-Calvo M, Fischer A, Bushman FD et al. Is normal hematopoiesis maintained solely by long-term multipotent stem cells? Blood 2011;117: 4420-4424.
28. Nakano T. Hematopoietic stem cells: Generation and manipulation. Trends Immunol 2003;24: 589-594.
29. Osgood EE. Number and distribution of human hemic cells. Blood 1954;9: 1141-1154.
30. Pichardo JC, Trindade AA, Brindle JM et al. Method for estimating skeletal spongiosa volume and active marrow mass in the adult male and adult female. J Nucl Med 2007;48: 1880-1888.
31. Trentin JJ. Determination of bone marrow stem cell differentiation by stromal hemopoietic inductive microenvironments (HIM). Am J Pathol 1971;65: 621-628.
32. Awaya N, Rupert K, Bryant E et al. Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation. Exp Hematol 2002;30: 937-942.
33. Murakami Y, Kosaka H, Maeda Y et al. Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: Implications for paroxysmal nocturnal hemoglobinuria. Blood 2002;100: 4116-4122.
34. Kwon KR, Ahn JY, Kim MS et al. Disruption of bis leads to the deterioration of the vascular niche for hematopoietic stem cells. Stem Cells 2010;28: 268-278.